Physician profile
Van Nguyen
NPI 1902337645
$9,342.20
in general payments reported to CMS, 2019-2025
11 companies · $5,141 in 2025
The $5,141 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $673 · 2022: $869 · 2023: $1,244 · 2024: $1,415 · 2025: $5,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,125 · Food and Beverage: $3,667 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,125.00 |
| Food and Beverage | $3,667.29 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nova Eye, INC. | $4,336.47 | 2025 | |
| Alcon Vision LLC | $1,341.27 | 2021-2025 | Hydrus Microstent, Centurion, Clareon |
| Abbvie INC. | $1,104.01 | 2022-2025 | |
| New World Medical,INC. | $993.10 | 2023-2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Sight Sciences, INC. | $812.59 | 2021-2023 | Omni Surgical System |
| Glaukos Corporation | $360.22 | 2022-2025 | Idosetr, Istent Infinite, Istent Infinite Trabecular Micro Bypass System |
| Allergan, INC. | $217.06 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $109.06 | 2022 | |
| Ocular Therapeutix, INC. | $30.84 | 2022 | |
| Gilead Sciences, INC. | $20.88 | 2024 | |
| Argenx US, INC. | $16.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Van Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.